Skip to main content

Table 2 Comorbidities and complications in COVID-19 positive and non-COVID patients with myasthenia

From: Impact of COVID-19 infection among myasthenia gravis patients- a Cerner Real-World DataTM study

Co-morbidities COVID Patients with myasthenia (n= 27) Non-COVID Patients with myasthenia (n=64) P-value
Hypertension 1 3.70% 4 6.25% 0.986
Diabetes mellitus 5 18.52% 6 9.38% 0.384
Obstructive Sleep apnea 5 18.52% 12 18.75% 0.979
Hyperlipidemia 9 33.33% 32 50.00% 0.144
Atrial fibrillation 3 11.11% 13 20.31% 0.452
Obesity 0 0.00% 1 1.56% 0.654
COPD 4 3.70% 13 4.69% 0.538
Complications COVID Patients with myasthenia (n= 27) Non-COVID Patients with myasthenia (n=64) P-value
Pneumonia 13 48.15% 28 43.75% 0.7
Septic shock 9 33.33% 13 20.31% 0.185
Acute Respiratory failure 10 37.04% 22 34.38% 0.808
Chronic Respiratory failure 1 3.70% 3 4.69% 0.725
  1. Abbreviation: COPD Chronic Obstructive Pulmonary Disease